Peregrine Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.8K | Sell |
866
-68,008
| -99% | -$1.16M | ﹤0.01% | 316 |
|
|
2025
Q1 | $4.4M | Buy |
68,874
+15,070
| +28% | +$962K | 0.15% | 219 |
|
|
2024
Q4 | $6.54M | Buy |
53,804
+11,965
| +29% | +$1.45M | 0.19% | 155 |
|
|
2024
Q3 | $5.23M | Buy |
41,839
+5,545
| +15% | +$693K | 0.16% | 210 |
|
|
2024
Q2 | $5.73M | Buy |
36,294
+780
| +2% | +$123K | 0.17% | 210 |
|
|
2024
Q1 | $4.6M | Sell |
35,514
-2,949
| -8% | -$382K | 0.13% | 240 |
|
|
2023
Q4 | $3.71M | Sell |
38,463
-6,715
| -15% | -$648K | 0.11% | 240 |
|
|
2023
Q3 | $5.48M | Buy |
45,178
+5,166
| +13% | +$626K | 0.16% | 226 |
|
|
2023
Q2 | $4.58M | Sell |
40,012
-30,565
| -43% | -$3.5M | 0.12% | 243 |
|
|
2023
Q1 | $9.73M | Buy |
70,577
+5,576
| +9% | +$769K | 0.28% | 146 |
|
|
2022
Q4 | $8.42M | Sell |
65,001
-9,338
| -13% | -$1.21M | 0.26% | 176 |
|
|
2022
Q3 | $8.22M | Sell |
74,339
-21,825
| -23% | -$2.41M | 0.27% | 178 |
|
|
2022
Q2 | $7.21M | Sell |
96,164
-74
| -0.1% | -$5.55K | 0.22% | 209 |
|
|
2022
Q1 | $7.52M | Buy |
+96,238
| New | +$7.52M | 0.18% | 223 |
|